DEA Extends Telehealth Flexibilities for Controlled Substance Prescribing Through 2024
- October 13, 2023
The Drug Enforcement Administration (DEA) has extended for a second time telehealth flexibilities for prescribing controlled substances that were put in place during the COVID-19 pandemic.
ARTICLE TAGS
You must be logged in to access this content.